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F24. OMEGA-6 PUFA METABOLISM DISTURBED 
IN PHOSPHO- AND SPHINGOLIPIDS IN 
NEUROLEPTIC-NAÏVE FIRST-EPISODE 
SCHIZOPHRENIA PATIENTS – A FATTY ACID 
PROFILING STUDY IN FIVE LIPID FRACTIONS
Kerstin Langbein*,1, Christian Fleischer1, Katrin Kuhnt2, 
Stefan Smesny1
1Jena University Hospital; 2Friedrich-Schiller-University Jena
Background: Alterations of polyunsaturated fatty acid (PUFA) levels are a 
well-replicated finding in schizophrenia research. There is however a con-
troversy about the origin of this abnormality and its importance in the 
pathogenesis of schizophrenic illness. To investigate the influence of nutri-
tion, in this study we investigate different aspects of fatty acid metaboliza-
tion in a cohort of neuroleptic naïve first-episode schizophrenia patients 
(FEP) and a group of healthy controls (HC) matched for age and gender.
Methods: In 33 FEP (25.8 ± 4.8y, male 60.6% 20/33) and 32 HC (24.9 ± 4.6y, 
male 53.1% 17/32) fatty acid profile was investigated by gas chromatography 
in blood plasma lipids of the triacylglycerol (TAG) fraction (closely related 
to fat consumption within recent days, rich in SFA, MUFA (~50%), and LA 
(C18:2n6)), the cholesterol ester (CE) fraction (dependent on fat consump-
tion within recent days, rich in LA (C18:2n6)(~51%), SFA and PUFA), and 
the plasma phospholipid (PL) fraction (reflecting fat consumption of the 
last weeks to month, rich in SFA (~50%), AA (~7%), and LA (C18:2n6). In 
erythrocyte membranes (sensitive to fat consumption within weeks to month), 
fatty acid profile was investigated in phospholipids of the phosphoethanola-
min (PE) fraction (rich in PUFA (~45%), AA (C20:4n6) and SFA) and of 
the sphingomyelin (SM) fraction (rich in long chain SFA (>70%) and MUFA 
(including NA C24:1c15). Psychopathology was assessed using the PANSS, 
BPRS-E and SCL-90-R ratings. Statistical analysis included multi- and uni-
variate ANOVA, non-parametric tests and correlation analysis.
Results: In the plasma PL fraction and in the lipid fractions of erythrocyte 
membranes (PE, SM) that are less influenced by recent nutrition, patients 
showed generally reduced omega-6 PUFA levels, particularly in terms of 
AA in the SM fraction. While PUFA of the PL and PE fraction were posi-
tively correlated in HC, this was not the case in the FEP group.
Discussion: Our results support the previous finding of a general omega-6 
PUFA deficit in FEP. The decrease points towards an endogenous regula-
tion deficit that is independent of recent nutrition, might affect the metab-
olism of grey and white matter structural components, and could cause 
alterations of AA downstream functions. While correlation analysis in HC 
strongly suggests that nutrition and supplementation have the potential to 
influence PUFA availability, inner transport and metabolization pathways 
seem to be disturbed in FEP.
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Background: The NEURAPRO multicentre randomised controlled trial 
(RCT) of  long-chain polyunsaturated omega-3 fatty acids (ω-3 PUFAs) 
(‘fish oil’) in combination with high-quality psychosocial intervention 
(cognitive behavioural case management [CBCM]) vs. placebo in combi-
nation with CBCM in young people at ultrahigh risk (UHR) of  psychosis 
showed that the group allocated to fish oil had no clinical benefits over 
the placebo group. However, a limitation of  the trial was that adherence 
with the study medication was relatively low. Furthermore, although RCTs 
are placed at the top of  the evidence hierarchy, this methodology has lim-
itations in fish oil RCTs, since the test agent is not only present in the 
intervention group, but ω-3 fats are present in the diet and in the tissues 
of  all participants. A biomarker analysis of  ω-3 changes during the trial 
can ultimately determine the efficacy of  ω-3 supplementation in this trial.
Methods: The NEURAPRO study was conducted from March 2010 to 
September 2014, in 10 specialized early psychosis treatment services in Australia, 
Asia, and Europe. In this study of 304 young people at UHR for psychotic dis-
orders, 153 (50.3%) were allocated to ω-3 PUFAs and 151 (49.7%) to placebo. In 
all, 139 (45.7%) were male; mean (SD) age was 19.1 (4.6) years. The primary out-
come was transition to psychosis assessed with the Comprehensive Assessment of 
the At-Risk Mental State. Secondary outcomes were levels of psychopathology 
and functioning assessed by the Brief Psychiatric Rating Scale (BPRS), the Scale 
for the Assessment of Negative Symptoms (SANS), the Montgomery Asberg 
Depression Rating Scale (MADRS), the Young Mania Rating Scale (YMRS), 
the Social and Occupational Functioning Assessment Scale (SOFAS), and the 
Global Functioning: Social and Role scales). Levels of ω-3 PUFAs in fish oil, 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (amongst other 
fatty acids) were measured as percentage of total fatty acids in erythrocytes at 
baseline and at month 6 (end-of-intervention). We examined changes in cell mem-
brane levels of EPA and DHA, as measures of ω-3 intake independent of source. 
Data were analysed as a single cohort. Cox proportional hazards models and lin-
ear regression analyses were used to examine relationships between the ω-3 index 
(EPA+DHA) with clinical outcomes at month 6 and 12.
Results: When analysed as a single cohort, no association was observed 
between the ω-3 index and transition to psychosis at any follow-up time 
point but increase of  the ω-3 index was found significantly related with 
most of  the functional and symptomatic measures at month 6 and 12, in 
linear regression models adjusting for relevant baseline factors (i.e., func-
tioning, psychopathology, ω-3 index and smoking). The models revealed 
consistent results, with low functioning or high psychopathology at base-
line, low levels of  ω-3s at baseline and increase of  the ω-3 index inde-
pendently predicting clinical improvements at in this sample.
Discussion: In contrast to our RCT analysis, this study using biomarkers 
shows that increase in erythrocyte ω-3 PUFAs may improve clinical out-
comes of UHR patients. The results also imply that people with low DHA 
and EPA levels may benefit more from supplementation with fish oil. The 
analysis also highlights shortcomings of the RCT design in situations when 
the tested intervention is available outside the study.
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Background: Early detection of psychosis is an important topic in psychia-
try and is involving ever younger patient groups. Yet, developmental issues 
are still under researched. Thus, we examined risk symptoms and criteria in 
8-40-year-olds from the general population.
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Methods: Clinical high-risk symptoms, i.e. attenuated and transient psy-
cvhotic symptoms (APS, BIPS) as well ascognitive and perceptive basic 
symptoms (BS), were assessed by well-trained psychologists performed 
assessments of risk symptoms, using established interviews. Differentiating 
between perceptive and non-perceptive/cognitive phenomena, impact of 
age groups on risk symptoms and their clinical significance (current psy-
chosocial functioning deficits or non-psychotic DSM-IV axis-I disorder) 
was assessed by logistic regression analyses.
Results: Altogether, 9.9% of interviewees (N=689) reported APS, and 
18.1% BS; 1.3% met APS, 3.3% COPER and 1.2% COGDIS criteria. For 
APS, an age effect was detected around age 16: compared to 16-40-year-
olds, 8-15-year-olds reported more perceptive APS and lesser clinical signif-
icance of non-perceptive APS. Similar age effects of BS on prevalence and 
clinical significance that differed between perceptive and cognitive BS and 
followed brain maturation patterns were also detected: around age 18 for 
perceptive and in the early twenties for cognitive BS.
Discussion: These findings strongly suggest differential developmental fac-
tors affecting prevalence and clinical significance of APS and BS: While 
neurocognitive maturation might influence the presence of APS, brain mat-
uration seems to influence the presence of BS. These findings emphasize the 
need to address the differential effects of perceptive and non-perceptive risk 
phenomena, and their interaction with age, also in terms of conversion to 
psychosis, in future studies.
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Background: Latent liability for schizophrenia (schizotypy) is expressed in 
various combinations of cognitive, psychological, and behavioural charac-
teristics evident in the general population. Historical models propose that 
distinct classes of individuals expressing different forms of schizotypy may 
represent manifestations of differential levels of genetic and environmen-
tal risk for schizophrenia (or related illness). However, there has been little 
investigation of developmental models of schizotypy in childhood. Here, 
we sought to delineate latent profiles of schizotypy among children aged 
11–12  years, and to examine associations between emerging schizotypal 
profiles and parental history of mental illness (as a proxy for genetic risk), 
early life trauma, and childhood contact with health services for mental 
illness up to age 13 years.
Methods: Latent profiles of schizotypy were distinguished among 22,137 
children (mean age=11.9 years) for whom intergenerational records of health 
service contact for mental illness and child protection reports were linked to 
the Middle Childhood Survey (MCS) within the NSW Child Development 
Study.1 Selected MCS items were used to index schizotypy across six 
domains (Unusual Experiences, Cognitive Disorganisation, Impulsive Non-
conformity, Introversion, Dysphoria and Self-Other disturbance). Using 
Latent Profile Analyses (LPA), four groups emerged according to patterns of 
expression across these domains; membership of three putative schizotypy 
groups were examined in relation to the likelihood of being exposed to child-
hood maltreatment and parental mental illness, and the child’s own mental 
illness up to age 13 years, relative to the no risk group.
Results: Four classes emerged from the LPA: (1) ‘schizotypy’ (n=1323; 6%); 
(2) ‘dysphoric pseudo-schizotypy’ (n=4261, 19%); (3) ‘introverted pseudo-
schizotypy’ (n=4473; 20%) and; (4) ‘no psychopathology’ (no-risk, n=12,080; 
55%). Children in the schizotypy group had the greatest odds of being the 
subject of a child protection report (OR=2.9, 95% CI 2.6–3.3) and in con-
tact with health services for mental illness by age 13 years (OR=2.7, 95% CI 
2.2–3.3), relative to the no-risk group. The odds of child protection reports 
and childhood mental disorders were smaller, yet significantly increased, 
among dysphoric pseudo-schizotypy (ORs=1.9 and 1.8, respectively) and 
introverted pseudo-schizotypy (ORs=1.7 and 1.4, respectively), relative to 
the no-risk group. Parental mental illness exposure was greatest among the 
schizotypy (OR=2.3, 95% CI 2.0–2.6) subgroup, and was also increased in 
dysphoric pseudo-schizotypy (OR=1.6, 95% CI 1.5–1.8) and introverted 
pseudo-schizotypy (OR=1.4, 95% CI 1.3–1.5), relative to the no-risk group.
Discussion: We provide evidence for distinct subtypes of children expressing different 
forms of schizotypy among a large Australian sample from the general population. 
The subgroup of children labeled ‘schizotypy’ (6%) characterized by high levels of 
cognitive disorganisation, impulsive non-conformity, introversion, and self-other dis-
turbance may be at highest risk for developing schizophrenia or other mental illness 
in adulthood, and had a greater likelihood of childhood maltreatment and parental 
mental illness history, than other ‘pseudo-schizotypy’ groups.
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Background: Cortical thickness changes continuously throughout healthy 
adolescence reflecting ongoing maturation. In schizophrenia, distributed 
abnormalities in cortical maturation are suspected. To study if  these dis-
tributed changes are a result of a co-ordinated process, we investigated the 
structural covariance among the longitudinal post-onset thickness changes 
that occur across various brain regions in adolescent-onset schizophrenia.
Methods: 19 healthy adolescents and 18 age-matched patients with early-onset 
schizophrenia were scanned twice (~2 years’ interval). The rate of change in 
cortical thickness was estimated both at lobar and sulcogyral level. Group level 
structural covariance was studied using a graph theoretical framework.
Results: At baseline, patients had distributed reduction in cortical thick-
ness compared to controls, though this deviation was abolished over the 
next 2  years. Occipital cortex had a significantly deviant rate of change 
in patients (0.8% increase per year) compared to controls (2.5% thinning/
year). Patients had a significant increase in covariance of right anterior 
insula and calcarine sulcus with rest of the brain.
Discussion: Post-onset structural changes in EOS are not a result of ran-
dom, mutually independent processes. A spatially interconnected reorgan-
ization process, distinct from normal maturational events may underlie 
these distributed changes.
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